Evidence map›Paper›PMID 34903205›Full record

ArticleBMC public health2021

Non-communicable diseases in the southwest of Iran: profile and baseline data from the Shahrekord PERSIAN Cohort Study.

Ali Ahmadi, Majid Shirani, Arsalan Khaledifar, Morteza Hashemzadeh, Kamal Solati, Soleiman Kheiri, Mehraban Sadeghi, Abdollah Mohammadian-Hafshejani, Hadi Raeisi Shahraki, Alireza Asgharzadeh and 7 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Prevalence of Multimorbidity in the Middle East: A Systematic Review of Observational Studies.International journal of environmental research and public health · 2022
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Ali AhmadiModeling in Health Research Center, Shahrekord University of Medical Sciences, P.O. Box: 881-55383, Shahrekord, Iran. ahmadi@skums.ac.ir.ORCID 0000-0002-1588-2136
Majid ShiraniDepartment of Urology, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Arsalan KhaledifarModeling in Health Research Center, Shahrekord University of Medical Sciences, P.O. Box: 881-55383, Shahrekord, Iran.
Morteza HashemzadehCellular and Molecular Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Kamal SolatiDepartment of Psychiatry, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Soleiman KheiriModeling in Health Research Center, Shahrekord University of Medical Sciences, P.O. Box: 881-55383, Shahrekord, Iran.
Mehraban SadeghiDepartment of Environmental Engineering, School of Public Health, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Abdollah Mohammadian-HafshejaniModeling in Health Research Center, Shahrekord University of Medical Sciences, P.O. Box: 881-55383, Shahrekord, Iran.
Hadi Raeisi ShahrakiModeling in Health Research Center, Shahrekord University of Medical Sciences, P.O. Box: 881-55383, Shahrekord, Iran.
Alireza AsgharzadehSchool of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Ali Zamen SalehifardSchool of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Masoumeh MousaviModeling in Health Research Center, Shahrekord University of Medical Sciences, P.O. Box: 881-55383, Shahrekord, Iran.
Elaheh ZareanModeling in Health Research Center, Shahrekord University of Medical Sciences, P.O. Box: 881-55383, Shahrekord, Iran.
Reza GoujaniModeling in Health Research Center, Shahrekord University of Medical Sciences, P.O. Box: 881-55383, Shahrekord, Iran.
Seyed Saeed Hashemi NazariSafety Promotion and Injury Prevention Research Center, Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hossein PoustchiLiver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Pierre-Antoine DuguéPrecision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
Shahrekord University of Medical Sciences · IRShahid Beheshti University of Medical Sciences · IRTehran University of Medical Sciences · IRThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCritical inter-provincial differences within Iran in the pattern of non-communicable diseases (NCDs) and difficulties inherent to identifying prevention methods to reduce mortality from NCDs have challenged the implementation of the provincial health system plan. The Shahrekord Cohort Study (SCS) was designed to address these gaps in Chaharmahal and Bakhtiari, a province of high altitude in the southwest of Iran, characterized by its large Bakhtiari population, along with Fars and Turk ethnicity groups.

methodsThis ongoing cohort, a prospective, large-scale longitudinal study, includes a unique, rich biobank and was conducted for the first time in Chaharmahal and Bakhtiari Province in Iran. SCS is a part of the PERSIAN (Prospective Epidemiological Research Studies in IrAN) cohort. The study began in 2015, recruited 10075 participants (52.8% female, 47.2% male) from both urban (n=7034) and rural (n=3041) areas, and participants will be annually followed up for at least 15 years. A cross-sectional analysis was conducted using baseline data from the SCS, using descriptive statistics and logistic regression. Data analysis was performed using Stata software.

resultsThe prevalence of NCDs was 9.8% for type 2 diabetes, 17.1% for hypertension, 11.6% for thyroid disease, 0.2% for multiple sclerosis and 5.7, 0.9 and 1.3% for ischemic heart disease, stroke and myocardial infarction, respectively. The prevalence of multimorbidity (≥2 NCDs) was higher in women (39.1%) than men (24.9%). The means (standard deviations) of age, BMI, systolic blood pressure and fasting blood glucose were 49.5 (9) years, 27.6 (4.6) kg/m

conclusionsThe SCS provides a platform for epidemiological studies that will be useful to better control NCDs in the southwest of Iran and to foster research collaboration. The SCS will be an essential resource for identifying NCD risk factors in this region and designing relevant public health interventions.

Indexed as

Diabetes Mellitus, Type 2HypertensionNoncommunicable DiseasesCohort StudiesCross-Sectional StudiesFemaleHumansIranLongitudinal StudiesMaleMiddle AgedPrevalenceProspective StudiesRisk FactorsCohortMultimorbidityNon-communicable diseasesPERSIANRisk factors

Identifiers

PMID34903205
PMCPMC8670056
OpenAlexW4200248792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.